DF
Drug FarmDrug Farm is a biotech developing AI-designed small-molecule drugs for rare and immune-inflammatory diseases, led by DF-003, a Phase 3 ALPK1 inhibitor for ROSAH syndrome.
2 Pulse stories
TB
Triveni BioTriveni Bio develops genetics-informed antibody and bispecific therapeutics for immunological and inflammatory diseases.
2 Pulse stories
Total Raised
$138M
$272M
Drug FarmTriveni Bio
Last ValuationNot disclosed
Biotech
Sector
Biotech
2015
Founded
2023
Shanghai, China / New York, NY
HQ
Waltham, Massachusetts
Private
Status
Private
Drug Farm investors
Shanghai Pudong Leading Area Investment CenterShanghai Puxing Collaborative Private Equity FundDetong CapitalWuXi AppTecBioVeda China FundYD CapitalBetta CapitalWedo Venture Management
Triveni Bio investors
Atlas VentureCormorant Asset ManagementAscenta CapitalJanus Henderson InvestorsDeep Track CapitalOrbiMedViking Global InvestorsFidelity Management & Research
Data from Value Add Pulse coverage and company research — see the full threads for Drug Farm and Triveni Bio.